Extended Release Subdermal Implant Preceptorship Program
This online course will review up-to-date evidence on the effectiveness of LARCs, uptake statistics, and conceptualize the current needs for expanding contraceptive options in Canada. In particular, emerging evidence has shown that etonogesterel subdermal implant is a highly effective contraception option. Etonogesterel subdermal implant will be reviewed in detail, and by the end of the module you will have an understanding of the benefits and risks of this LARC option, how to initiate its use in clinical settings, and overall gain expertise in insertion, localization and removal. Overview of etonogestrel subdermal implant will include review of the mechanism of action, pharmacokinetics, side effects, safety, and key counselling topics. Furthermore, this module outlines who should be offered the option of etonogesteral subdermal implant and when, contraindications for use, and appropriate timing of insertion. Finally, special topic areas are addressed such as etonogesteral subdermal implant in lactating women, exposure during pregnancy, among women who have obesity, adolescents, and extended use.
If you wish to be paired with a preceptor for virtual hands-on training, please email us at email@example.com. All preceptorships must be arranged through the SOGC after completion of the online modules.
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Society of Obstetricians and Gynaecologists of Canada. You may claim a maximum of 4.0 hours for this course.
This training program is supported by an educational grant from Merck.
Please login to register.